NASDAQ:DOX - Amdocs Stock Price, News, & Analysis

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs declared a quarterly dividend on Thursday, November 8th. Shareholders of record on Monday, December 31st will be given a dividend of $0.25 per share on Friday, January 18th. This represents a $1.00 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date of this dividend is Friday, December 28th. View Amdocs' Dividend History.

Amdocs declared that its Board of Directors has authorized a stock buyback program on Thursday, November 9th 2017, which permits the company to buyback $800,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board of directors believes its stock is undervalued.

Amdocs Limited (NASDAQ:DOX) announced its quarterly earnings results on Thursday, November, 8th. The technology company reported $0.90 EPS for the quarter, missing analysts' consensus estimates of $0.92 by $0.02. The technology company earned $1 billion during the quarter, compared to the consensus estimate of $1 billion. Amdocs had a return on equity of 15.06% and a net margin of 8.92%. Amdocs's revenue for the quarter was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.94 earnings per share. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, February 5th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8445137152.

Amdocs updated its first quarter earnings guidance on Thursday, November, 8th. The company provided earnings per share (EPS) guidance of $0.95-$1.01 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.06. The company issued revenue guidance of $990-$1.03 billion, compared to the consensus revenue estimate of $1.02 billion.Amdocs also updated its FY 2019 guidance to $4.15-4.31 EPS.

7 analysts have issued 12 month price targets for Amdocs' shares. Their predictions range from $60.20 to $77.00. On average, they anticipate Amdocs' share price to reach $72.0286 in the next year. This suggests a possible upside of 18.4% from the stock's current price. View Analyst Price Targets for Amdocs.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Amdocs.

News coverage about DOX stock has been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Amdocs earned a news sentiment score of -1.4 on InfoTrie's scale. They also assigned headlines about the technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future.

Some companies that are related to Amdocs include Wipro (WIT), Verisign (VRSN), NTT DATA CORP/ADR (NTDTY), EPAM Systems (EPAM), Aspen Technology (AZPN), Zscaler (ZS), GEMALTO NV/S (GTOMY), Sogou (SOGO), Luxoft (LXFT), Virtusa (VRTU), Glu Mobile (GLUU), PROS (PRO), Endava (DAVA), Perficient (PRFT) and Monotype Imaging (TYPE).

Amdocs' stock is owned by many different of retail and institutional investors. Top institutional shareholders include BTIM Corp. (0.16%), Denali Advisors LLC (0.04%), Nisa Investment Advisors LLC (0.04%), State of Alaska Department of Revenue (0.03%), Bowling Portfolio Management LLC (0.03%) and Bristlecone Advisors LLC (0.01%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Bristlecone Advisors LLC, Nisa Investment Advisors LLC, CENTRAL TRUST Co, Bowling Portfolio Management LLC, Meeder Asset Management Inc. and First Hawaiian Bank.

DOX stock was acquired by a variety of institutional investors in the last quarter, including Denali Advisors LLC, BTIM Corp., Cerebellum GP LLC and State of Alaska Department of Revenue.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $60.81.

Amdocs has a market capitalization of $8.49 billion and generates $3.97 billion in revenue each year. The technology company earns $354.39 million in net income (profit) each year or $3.74 on an earnings per share basis. Amdocs employs 24,381 workers across the globe.

The official website for Amdocs is http://www.amdocs.com.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]